Experience

Oxford BioTherapeutics

• United Kingdom
• Biotechnology
• 1 - 100 Employee

• Vice President Finance and U.S. Operations

  • 2021 - Present



Sayre Consulting

• United States
• Biotechnology Research

• Principal Consultant

  • 2019 - 2021

  Providing financial consulting to pharma and biotech clients. Providing financial consulting to pharma and biotech clients.



Dynavax Technologies

• United States
• Biotechnology Research
• 200 - 300 Employee

• Senior Director, Financial Planning and Analysis

  • 2011 - 2019

  Managed and mentored a three-member team overseeing long/short-term business and financial planning, treasury management, risk management, contracting, and decision support activities.Oversaw strategic and tactical support for a 10,000-patient Phase 3 safety study and Phase 1, 2, and 3 clinical trials for oncology, lupus, asthma, vaccine, and post-marketing initiatives.Improved cash requirements planning and routine reporting, defined cost accounting methodologies, and enhanced insights into the financial implications of marketing program decisions. Led diligence efforts on a $175 million debt agreement.Implemented gross to net reporting for a new agency approved vaccine.Guided development of a cost model to guide forecasting of long-term product margins.



KAS Consulting

• United States
• Renewable Energy Semiconductor Manufacturing
• 1 - 100 Employee

• Principal

  • 2010 - May 2012

  Business support for a life sciences tool company, resulting in $30M of financing proceeds.Guided three entrepreneurs developing business plans. Business support for a life sciences tool company, resulting in $30M of financing proceeds.Guided three entrepreneurs developing business plans.



Fluidigm Corporation

• United States
• Biotechnology Research
• 1 - 100 Employee

• Senior Director, Finance

  • 2008 - 2010

  Directed business/financial planning and treasury management, and led a three-member team. Championed visibility in operating expenses and deepened understanding into product margins. Collaborated with the VP of North American Sales to create a model for sales force effectiveness.. Directed business/financial planning and treasury management, and led a three-member team. Championed visibility in operating expenses and deepened understanding into product margins. Collaborated with the VP of North American Sales to create a model for sales force effectiveness..



XDx, Inc.

• United States

• Senior Director, Finance

  • 2007 - 2008

  Coached a team of two strategizing and executing planning, decision support, risk management, and treasury management functions. Led an end-to-end strategic planning process. Instituted reporting processes for gross margin performance with increased volume.Established accrual methodology to increase visibility and accuracy in clinical trial costs. Coached a team of two strategizing and executing planning, decision support, risk management, and treasury management functions. Led an end-to-end strategic planning process. Instituted reporting processes for gross margin performance with increased volume.Established accrual methodology to increase visibility and accuracy in clinical trial costs.



Applied Biosystems

• Director, Finance

  • Aug 1997 - Mar 2007

  Led and developed a fifteen member team with ownership of financial oversight, business partnerships, and business decision support while managing controllership functions for the four-unit Molecular Biology Division. Prepared annual operating plans, forecasts, and analysis of divisional, business unit, and product line results with global P&L accountability. Served as a key leader on the Product Approval Committee (PAC).Provided in-licensing and out-licensing decision support.Advanced due diligence activities for two multi million-dollar acquisitions.